WAM
AMPE

Wolverine Asset Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Wolverine Asset Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1
Closed -$28K – 2063
2015
Q1 		$28K Buy
+1
New +$1.71K ﹤0.01% 1383

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wolverine Asset Management's AMPE Position: Q2 2015 in Review

Wolverine Asset Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2015, closing a stake of 58 shares — an estimated $131K sold.

Wolverine Asset Management first reported a position in AMPE in Q4 2013 and held it in 6 quarters. The position peaked at $722K in Q2 2014. 64 funds tracked by Wall St. Rank hold AMPE as of Q2 2015.

  • Wolverine Asset Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2015 after selling out during the quarter.
  • Wolverine Asset Management sold 58 Ampio Pharmaceuticals Inc. shares in Q2 2015, an estimated $131K.
  • Wolverine Asset Management first reported a position in Ampio Pharmaceuticals Inc. in Q4 2013 and held it in 6 quarters.
  • Wolverine Asset Management's Ampio Pharmaceuticals Inc. position peaked at $722K in Q2 2014.
  • 64 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2015.

Based on Wolverine Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.